Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-eluting stents.

Jeffrey J Popma1, Mark Tulli

  • 1Department of Internal Medicine (Cardiovascular Division), Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. jpopma@partners.org

Cardiology Clinics
|June 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Postrranscatheter Aortic Valve Replacement Heart Failure Hospitalization and Outcomes in Older Patients.

Journal of the American Heart Association·2026
Same author

Angiography-Derived Fractional Flow Reserve to Guide PCI.

The New England journal of medicine·2026
Same author

Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2025
Same author

Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2025
Same author

Trends and Late Outcomes in Elderly Patients Undergoing Mitral Valve Interventions in the United States.

JACC. Cardiovascular interventions·2025
Same author

Outcomes After Transcatheter Aortic Valve Replacement Among Medicare Beneficiaries: The Impact of Frailty and Social Vulnerability.

Structural heart : the journal of the Heart Team·2025

Drug-eluting stents have revolutionized percutaneous coronary intervention, offering advanced treatment for coronary artery disease. These stents release medication to improve patient outcomes beyond traditional angioplasty.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Percutaneous coronary intervention (PCI) has advanced significantly, with coronary stents largely replacing balloon angioplasty over the last 25 years.
  • Early stent improvements in the 1990s paved the way for a major breakthrough in the early 2000s: drug-eluting stents (DES).

Purpose of the Study:

  • To review the evolution and current landscape of drug-eluting stent technology.
  • To describe clinically available and investigational DES programs for coronary artery disease management.

Main Methods:

  • Review of historical development and technological advancements in coronary stent design.
  • Analysis of various drug-eluting stent platforms, including delivery systems, polymer coatings, and eluted drugs.

Related Experiment Videos

  • Compilation of information on currently marketed and late-stage developmental DES.

    • Main Results:

    • Drug-eluting stents represent a significant advancement over bare-metal stents and balloon angioplasty.
    • DES utilize controlled drug release from polymer coatings to enhance therapeutic efficacy.
    • Diverse DES designs exist, differing in drug, polymer, and delivery platform.

    Conclusions:

    • Drug-eluting stents have become a cornerstone in treating coronary artery disease, offering improved outcomes.
    • Ongoing research and development continue to refine DES technology for better patient care.
    • This review provides an overview of available and emerging DES options for clinicians.